【康华生物：股东宁波圣道及其一致行动人计划减持不超过2.44%公司股份】康华生物(300841.SZ)公告称，股东宁波圣道及其一致行动人淄博泰格计划在公告披露之日起3个交易日后的3个月内，以集中竞价和/或大宗交易方式减持公司股份不超过3,165,765股，即不超过剔除公司回购专用账户股份后总股本的2.4362%。减持原因为自身资金需求，减持股份来源为公司首次公开发行前已发行的股份及资本公积转增股本取得的股份。

金融界2025-07-01

康华生物(300841.SZ)公告称，股东宁波圣道及其一致行动人淄博泰格计划在公告披露之日起3个交易日后的3个月内，以集中竞价和/或大宗交易方式减持公司股份不超过3,165,765股，即不超过剔除公司回购专用账户股份后总股本的2.4362%。减持原因为自身资金需求，减持股份来源为公司首次公开发行前已发行的股份及资本公积转增股本取得的股份。

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2548078720?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-01 21:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2548078720","market":"hk","top_or_hot":-1,"title":"【康华生物：股东宁波圣道及其一致行动人计划减持不超过2.44%公司股份】康华生物(300841.SZ)公告称，股东宁波圣道及其一致行动人淄博泰格计划在公告披露之日起3个交易日后的3个月内，以集中竞价和/或大宗交易方式减持公司股份不超过3,165,765股，即不超过剔除公司回购专用账户股份后总股本的2.4362%。减持原因为自身资金需求，减持股份来源为公司首次公开发行前已发行的股份及资本公积转增股本取得的股份。","media":"金融界","content":"<div>\n<p>康华生物(300841.SZ)公告称，股东宁波圣道及其一致行动人淄博泰格计划在公告披露之日起3个交易日后的3个月内，以集中竞价和/或大宗交易方式减持公司股份不超过3,165,765股，即不超过剔除公司回购专用账户股份后总股本的2.4362%。减持原因为自身资金需求，减持股份来源为公司首次公开发行前已发行的股份及资本公积转增股本取得的股份。</p>\n\n<a href=\"https://24h.jrj.com.cn/2025/07/01215951424411.shtml\">网页链接</a>\n\n</div>\n","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【康华生物：股东宁波圣道及其一致行动人计划减持不超过2.44%公司股份】康华生物(300841.SZ)公告称，股东宁波圣道及其一致行动人淄博泰格计划在公告披露之日起3个交易日后的3个月内，以集中竞价和/或大宗交易方式减持公司股份不超过3,165,765股，即不超过剔除公司回购专用账户股份后总股本的2.4362%。减持原因为自身资金需求，减持股份来源为公司首次公开发行前已发行的股份及资本公积转增股本取得的股份。</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【康华生物：股东宁波圣道及其一致行动人计划减持不超过2.44%公司股份】康华生物(300841.SZ)公告称，股东宁波圣道及其一致行动人淄博泰格计划在公告披露之日起3个交易日后的3个月内，以集中竞价和/或大宗交易方式减持公司股份不超过3,165,765股，即不超过剔除公司回购专用账户股份后总股本的2.4362%。减持原因为自身资金需求，减持股份来源为公司首次公开发行前已发行的股份及资本公积转增股本取得的股份。\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-01 21:59 北京时间&nbsp;&nbsp;&nbsp;<a href=https://24h.jrj.com.cn/2025/07/01215951424411.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>康华生物(300841.SZ)公告称，股东宁波圣道及其一致行动人淄博泰格计划在公告披露之日起3个交易日后的3个月内，以集中竞价和/或大宗交易方式减持公司股份不超过3,165,765股，即不超过剔除公司回购专用账户股份后总股本的2.4362%。减持原因为自身资金需求，减持股份来源为公司首次公开发行前已发行的股份及资本公积转增股本取得的股份。</p>\n\n<a href=\"https://24h.jrj.com.cn/2025/07/01215951424411.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"https://24h.jrj.com.cn/2025/07/01215951424411.shtml","article_id":"2548078720","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2548078720","pubTimestamp":1751378368,"columns":[],"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"康华生物(300841.SZ)公告称，股东宁波圣道及其一致行动人淄博泰格计划在公告披露之日起3个交易日后的3个月内，以集中竞价和/或大宗交易方式减持公司股份不超过3,165,765股，即不超过剔除公司回购专用账户股份后总股本的2.4362%。减持原因为自身资金需求，减持股份来源为公司首次公开发行前已发行的股份及资本公积转增股本取得的股份。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300841":"康华生物","BK0239":"医药制造"},"translate_title":"[Kanghua Bio: Shareholder Ningbo Shengdao and its concerted parties plan to reduce their holdings by no more than 2.44% of the company's shares] Kanghua Bio (300841. SZ) announced that shareholder Ningbo Shengdao and its concerted parties Zibo Tiger plan to reduce their holdings of the company's shares by no more than 3,165,765 shares through centralized bidding and/or block trading within 3 months after 3 trading days from the date of disclosure, that is, no more than 2.4362% of the total share capital after excluding the shares in the company's special account for repurchase. The reason for ","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300841":1},"content_text":"康华生物(300841.SZ)公告称，股东宁波圣道及其一致行动人淄博泰格计划在公告披露之日起3个交易日后的3个月内，以集中竞价和/或大宗交易方式减持公司股份不超过3,165,765股，即不超过剔除公司回购专用账户股份后总股本的2.4362%。减持原因为自身资金需求，减持股份来源为公司首次公开发行前已发行的股份及资本公积转增股本取得的股份。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2548078720","isCrawlerRequest":true}